Ignite Creation Date:
2025-12-24 @ 4:12 PM
Ignite Modification Date:
2026-04-02 @ 1:10 PM
Study NCT ID:
NCT05024266
Status:
UNKNOWN
Last Update Posted:
2021-08-27
First Post:
2021-08-10
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Tislelizumab Combined With Chemotherapy as Neoadjuvant Therapy for Stage IIIA-IIIB (N2) Lung Squamous Cell Carcinoma
Sponsor:
Organization: